Safe Baby Products Act
This article was originally published in The Tan Sheet
Executive Summary
Sen. Kirsten Gillibrand, D-N.Y., introduces S. 295 to direct FDA to investigate cosmetics and personal care marketed to and used by children, according to April 29 release. The bill also would require FDA "to test a wide range of children's personal-care products, publicly report the findings and establish good manufacturing practices to reduce or eliminate hazardous contaminants from products." The legislation responds to the Campaign for Safe Cosmetics' "Toxic Tub" report, which analyzed and identified children's products containing suspected carcinogens 1,4-dioxane and formaldehyde. At the time of the report's release, Gillibrand said she would explore legislation to have FDA more closely scrutinize baby products (1"The Rose Sheet" March 23, 2009, p. 3). Sens. Dianne Feinstein, D-Calif., and Charles Schumer, D-N.Y., are co-sponsors
You may also be interested in...
More “Toxic Tub” Fallout: Senator Gillibrand Decries “Total Lack Of Oversight”
Sen. Kirsten Gillibrand, D-N.Y., is the latest Democrat to speak out about what she perceives as "a complete and total lack of oversight" in the personal-care sector, based on findings from the Campaign for Safe Cosmetics "Toxic Tub" report
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.